CANF
Can-fite Biopharma·AMEX
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
Latest data update time: Updated on 2026-03-28
2.71 / 10Overall Score
UnderperformInvestment Rating
2.71 / 10Overall Score
UnderperformInvestment Rating
Is CANF a Buy, Sell, or Hold?
- Based on a composite score of 2.71/10, we rate CANF as a Underperform. Our analysis breaks down into 2.29/10 for Fundamentals, 1.31/10 for Technicals, and 3.62/10 for Sentiment, indicating the stock is likely to Face downward pressure.
What is the current technical signals for CANF?
Is CANF fundamentally strong?
What is the analyst consensus for CANF?
Is CANF a Buy, Sell, or Hold?
- Based on a composite score of 2.71/10, we rate CANF as a Underperform. Our analysis breaks down into 2.29/10 for Fundamentals, 1.31/10 for Technicals, and 3.62/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is CANF fundamentally strong?
What is the current technical signals for CANF?
What is the analyst consensus for CANF?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
